icon-folder.gif   Conference Reports for NATAP  
 
  EACS - 12th European AIDS Conference
November 11-14, 2009
Cologne, Germany
Back grey_arrow_rt.gif
 
 
 
The Effect of Antiretroviral Therapy Without CCR5-Antagonists on HIV-1 Tropism in the MOTIVATE Studies of Maraviroc in Treatment-Experienced Patients With R5 HIV-1
 
 
  Reported by Jules Levin
EACS Nov 13 2009 Cologne Germany
 
Perno CF1, Nelson M2, Waters L2, Clotet B3, Paredes R3, Heera J4, Mayer H5, Dang N6, Valdez H6, Zhen Luo7, Van Der Ryst E8
 
1University of Rome Tor Vergata, Italy
2Chelsea and Westminster Hospital, London, UK
3Fundacio irsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
4Pfizer Global R&D, New London, CT, USA
5Pfizer Inc, New York, NY, USA
6Pfizer Inc, Paris, France
7Pfizer Global R&D, Shanghai, China
8Pfizer Global R&D, Sandwich, UK
 

image002.gif

1Melby et al. J Infect Dis 2006; 194:238-246; 2Waters et al. 16th CROI, Montreal, Canada, 2009. Abstract 439a
 

image004.gif

image006.gif

1Berger et al. Annu Rev Immunol 1999; 17:657-700; 2Delobel et al. J Acquir Immune Defic Syndr. 2005;38:382-92; 3Souliť et al. AIDS 2007;21:2243-5; 4 Melby et al. J Infect Dis. 2006;194:238-246;
 

image008.gif

image010.gif

1Gulick et al. N Engl J Med. 2008;359:1429-1441

image012.gif

image014.gif

1Gulick et al. N Engl J Med. 2008;359:1429-1441

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif

image026.gif

image028.gif

image030.gif

image032.gif

image034.gif

image036.gif